# Coya Therapeutics Posts $0.45 Net Loss Per Share in Third Quarter

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54047
Published: 2026-11-11T13:58:48.000Z
Updated: 2026-11-11T13:58:48.000Z
Section: Business

> Collaboration revenue was $234,134 for the quarter ended Sept. 30, 2026.

Coya Therapeutics, Inc. recorded a net loss per share of $0.45 for the third quarter ended Sept. 30, 2026, while collaboration revenue totaled $234,134 for the same period.

The per-share loss was the same on a basic and diluted basis.